array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Natus Medical Incorporated"
["slug"]=>
string(35) "05e48-us-natus-medical-incorporated"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a"
["description"]=>
string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status."
["address_street"]=>
string(29) "6701 Koll Center Pkwy Ste 120"
["address_place"]=>
string(10) "Pleasanton"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1987-02-13"
["website_domain"]=>
string(9) "natus.com"
["website_url"]=>
string(17) "https://natus.com"
["industry_codes"]=>
array(1) {
[0]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(1480)
["article_count"]=>
int(148)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(74) "Why Natus takes over a German company and stands up to deindustrialization"
["snippet_en"]=>
string(186) "As one of the largest owner-managed regional companies, Natus has now taken over the Leipzig company GfN. Why the internationally active Trier-based company ensures expertise in Germany."
["url"]=>
string(136) "https://www.volksfreund.de/region/warum-natus-eine-deutsche-firma-uebernimmt-und-der-deindustrialisierung-die-stirn-bietet_aid-102036279"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1ccd09be-ff27-4337-a9fa-95c408b4bbc0"
["source"]=>
string(14) "volksfreund.de"
["publication_date"]=>
string(10) "2023-11-23"
["categories"]=>
array(5) {
[0]=>
string(25) "Business Model Resilience"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(21) "Competitive Behaviour"
[3]=>
string(11) "Acquisition"
[4]=>
string(23) "Supply Chain Management"
}
}
[1]=>
array(7) {
["title_en"]=>
string(83) "Natus Medical Incorporated Announces Closing of Acquisition of Micromed Holding SAS"
["snippet_en"]=>
string(196) "Newly merged organization brings together innovative neurodiagnostic and neuromonitoring solutions and experienced teams to offer a broader portfolio of products, services and support to customers"
["url"]=>
string(153) "https://www.finanznachrichten.de/nachrichten-2023-01/58086469-natus-medical-incorporated-announces-closing-of-acquisition-of-micromed-holding-sas-008.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/79d94c7e-7db1-482f-81e7-56b5e6a8acf1"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-01-18"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[2]=>
array(7) {
["title_en"]=>
string(103) "Natus Medical Incorporated: Natus Medical Incorporated has completed the acquisition of Micromed S.p.A."
["snippet_en"]=>
string(246) "Natus Medical Incorporated has agreed to acquire Micromed S.p.A. from ArchiMed SAS on November 2, 2022. The transaction is expected to close in early 2023, subject to obtaining regulatory approvals. William Blair & Company, L.L.C. has ... | 01/18"
["url"]=>
string(166) "https://www.zonebourse.com/amp/cours/action/NATUS-MEDICAL-INCORPORATE-62779406/actualite/Natus-Medical-Incorporated-a-acheve-l-acquisition-de-Micromed-S-p-A-42768850/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/36a1b5cd-7bcf-4168-934e-8cb5a3a6d596"
["source"]=>
string(14) "zonebourse.com"
["publication_date"]=>
string(10) "2023-01-18"
["categories"]=>
array(2) {
[0]=>
string(10) "Downsizing"
[1]=>
string(11) "Acquisition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(33) "Natus Medical to acquire Micromed"
["snippet_en"]=>
string(128) "Natus Medical announced today that it entered into a definitive agreement to acquire neurophysiology solution provider Micromed."
["url"]=>
string(61) "https://www.massdevice.com/natus-medical-to-acquire-micromed/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8e9030a1-c161-43ba-95a7-9f8b8db6e327"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2022-12-02"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[4]=>
array(7) {
["title_en"]=>
string(43) "HumanQ Raises $2M in Seed Funding - FinSMEs"
["snippet_en"]=>
string(136) "FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!"
["url"]=>
string(69) "https://www.finsmes.com/2022/09/humanq-raises-2m-in-seed-funding.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/6e6aea0f-6b1f-4788-929a-797610d2c414"
["source"]=>
string(11) "finsmes.com"
["publication_date"]=>
string(10) "2022-09-04"
["categories"]=>
array(2) {
[0]=>
string(6) "Merger"
[1]=>
string(11) "Acquisition"
}
}
[5]=>
array(7) {
["title_en"]=>
string(96) "ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value"
["snippet_en"]=>
string(159) "MIDDLETON, Wis., July 21, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical."
["url"]=>
string(171) "https://www.globenewswire.com/news-release/2022/07/21/2483746/31146/en/ArchiMed-completes-acquisition-of-Natus-Medical-Incorporated-for-1-2-billion-total-equity-value.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7613eb7c-d29b-4cf6-b321-1ce4d3dfb7e3"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2022-07-21"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[6]=>
array(7) {
["title_en"]=>
string(75) "Natus Medical Soars. It's Being Taken Private by ArchiMed for $1.2 Billion."
["snippet_en"]=>
string(62) "Natus Medical is being acquired by ArchiMed for a 29% premium."
["url"]=>
string(90) "https://www.barrons.com/articles/natus-medical-ntus-stock-archimed-acquisition-51650285338"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/4ce1b168-3508-4a2d-9874-19a103cdaf0a"
["source"]=>
string(11) "barrons.com"
["publication_date"]=>
string(10) "2022-04-18"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[7]=>
array(7) {
["title_en"]=>
string(88) "Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash"
["snippet_en"]=>
string(174) "Highlights: • Transaction values Natus Medical, Incorporated at approximately $1.2 billion total equity value• Pre-announces preliminary..."
["url"]=>
string(163) "https://www.globenewswire.com/news-release/2022/04/18/2423607/31146/en/Natus-Medical-Incorporated-to-be-acquired-by-ArchiMed-Group-for-33-50-per-share-in-cash.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/835fac45-ae6c-455d-ae94-fce19c19d950"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2022-04-18"
["categories"]=>
array(2) {
[0]=>
string(5) "SPACs"
[1]=>
string(11) "Acquisition"
}
}
[8]=>
array(7) {
["title_en"]=>
string(59) "Spectrum Plastics CEO is leaving to take over Natus Medical"
["snippet_en"]=>
string(111) "Natus Medical recently announced that it appointed Thomas Sullivan as president and CEO, effective December 27."
["url"]=>
string(104) "https://www.medicaldesignandoutsourcing.com/spectrum-plastics-ceo-is-leaving-to-take-over-natus-medical/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/ee428a4e-e083-4523-98ff-5aeac98d3910"
["source"]=>
string(31) "medicaldesignandoutsourcing.com"
["publication_date"]=>
string(10) "2021-12-20"
["categories"]=>
array(3) {
[0]=>
string(17) "Business Disputes"
[1]=>
string(12) "Board Change"
[2]=>
string(11) "Acquisition"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(23)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(12)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(11)
}
[3]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[4]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(5)
}
[6]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(3)
}
[10]=>
array(2) {
["name"]=>
string(5) "SPACs"
["count"]=>
int(3)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(2)
}
[21]=>
array(2) {
["name"]=>
string(22) "Shareholder Reputation"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(5) "Fraud"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(10) "Complaints"
["count"]=>
int(1)
}
}
}
05e48-us-natus-medical-incorporated
Natus Medical Incorporated
Location
California
Founded
1987-02-13
Website
https://natus.com
Articles
148 Articles
Category
Electromedical and Electrotherapeutic Apparatus
Description
Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.
As one of the largest owner-managed regional companies, Natus has now taken over the Leipzig company GfN. Why the internationally active Trier-based company ensures expertise in Germany.
Newly merged organization brings together innovative neurodiagnostic and neuromonitoring solutions and experienced teams to offer a broader portfolio of products, services and support to customers
Natus Medical Incorporated has agreed to acquire Micromed S.p.A. from ArchiMed SAS on November 2, 2022. The transaction is expected to close in early 2023, subject to obtaining regulatory approvals. William Blair & Company, L.L.C. has ... | 01/18
MIDDLETON, Wis., July 21, 2022 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.